Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
SINOVAC Board of Directors Prevails Against Advantech/Primes New York Lawsuit
New York Court Denies Advantech/Prime’s Petition for Emergency Injunctive Relief Clears Legal…
C.H. Robinson Launches an AI Agent to Help Shippers Adapt to the New National System for Classifying LTL Freight
The global logistics provider’s latest innovation with artificial intelligence also marks a…
Agora and WIZ.AI Partner to Deliver Enterprise-Ready AI Agent Solutions
Advanced AI agents from Agora and WIZ.AI can power call centers with multilingual…
Draganfly Announces Closing of US$13.75 Million Public Offering
Saskatoon, SK., June 12, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO)…
Databricks Launches Agent Bricks: A New Approach to Building AI Agents
Agent Bricks automatically optimizes AI agents on customers' unique data to deliver…
Databricks Launches Lakebase: a New Class of Operational Database for AI Apps and Agents
Fully-managed, Postgres database built to unify analytics and operations for intelligent apps…
XerpaAI Launches the Worlds First AI Growth Agent (AGA), Ushering in a New Era Beyond CMOs and CGOs
SINGAPORE, June 10, 2025 (GLOBE NEWSWIRE) -- Today marks a historic turning…
Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept”…
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor,…